Intelligent Bio Solutions (NASDAQ:INBS) Issues Quarterly Earnings Results

Intelligent Bio Solutions (NASDAQ:INBS) announced its quarterly earnings results on Thursday. The company reported ($0.50) earnings per share (EPS) for the quarter, Zacks reports. Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%.

Intelligent Bio Solutions Trading Down 5.8 %

INBS stock traded down $0.15 during trading on Thursday, hitting $2.35. 574,759 shares of the stock traded hands, compared to its average volume of 222,014. Intelligent Bio Solutions has a one year low of $1.00 and a one year high of $5.87. The company has a 50 day simple moving average of $1.53 and a 200 day simple moving average of $1.52.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.